SCHEMBL1084437

SCHEMBL1084437

Oc1ccccc1-c1nc(N2CCCC2c2cccs2)c2ccc(Cl)cc2n1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMAD3 P84022 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 6/20 0.39
KDM4E B2RXH2 2/20 0.39
PKM P14618 1/20 0.39
CHEK2 O96017 2/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
ALDH1A1 P00352 2/20 0.39
TSHR P16473 2/20 0.39
GAA P10253 1/20 0.38
GBA1 P04062 1/20 0.38
LMNA P02545 2/20 0.37
HIF1A Q16665 2/20 0.37
MAOA P21397 1/20 0.36
HTT P42858 1/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084114 0.89 KMT2A (0.43) SMAD3MEN1KMT2AMAPTKDM4E
SCHEMBL1083914 0.87 SMAD3 (0.43) SMAD3MEN1KMT2AMAPTKDM4E
SCHEMBL1084502 0.86 PDE10A (0.43) SMAD3MEN1KMT2AMAPTKDM4E
SCHEMBL1084507 0.86 MAPT (0.46) SMAD3MEN1KMT2AMAPTKDM4E
SCHEMBL1084433 0.85 SMAD3 (0.44) SMAD3MEN1KMT2AMAPTKDM4E
SCHEMBL1083967 0.84 SMAD3 (0.43) SMAD3MEN1KMT2AMAPTKDM4E
SCHEMBL1084171 0.83 SMAD3 (0.43) SMAD3MEN1KMT2AMAPTKDM4E
SCHEMBL1084182 0.83 SMAD3 (0.43) SMAD3MEN1KMT2AMAPTKDM4E
SCHEMBL1084582 0.81 POLB (0.42) SMAD3MEN1KMT2AMAPTKDM4E
SCHEMBL1084410 0.80 CHEK2 (0.43) SMAD3MEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed